IP Library Granted Patent US 12,419,991
Granted Patent B2
US 12,419,991 · App. 17/827,934 · Granted Sep 23, 2025

Bioenergetic bone

Inventors: Timothy Ganey (Tampa, FL); Wendy W. Weston (Miami, FL); Miguel Quevedo (Miami, FL); Stuart Oglesby (Miami, FL); Tracy Scott Anderson (Atlanta, GA)
Assignee: Vivex Biologics Group, Inc.
A61L27/3608A61K35/28A61K35/32A61L27/3604A61L27/365A61L27/3687A61L27/3691A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,419,991
App. No.
17/827,934
Granted
Sep 23, 2025
Kind
B2
Abstract

A biological composition has a mixture of mechanically selected allogeneic biologic material derived from bone marrow. The mixture has non-whole cellular components including vesicular components and active and inactive components of biological activity, cell fragments, cellular excretions, cellular derivatives, and extracellular components. The mixture including non-whole cell fractions including one or more of exosomes, transcriptosomes, proteasomes, membrane rafts, lipid rafts. The mixture is compatible with biologic function.

Claims (29)

1. A method of making a biological composition, comprising:

(a) grinding a cut vertebral body from a human cadaver donor to produce a mixture comprising crushed vertebral bone and bone marrow;

(b) mechanically separating cellular and non-cellular components of the bone marrow from the vertebral bone in the mixture by tumbling and sieving the vertebral bone from a decanted fluid of the bone marrow comprising cellular components comprising whole cells, and non-whole cellular components comprising non-whole cell components;

(c) concentrating the decanted fluid by centrifugation;

(d) filtering the decanted fluid through a blood filter to form a mixture including the cellular and non-whole cellular components and remove any remaining vertebral bone;

(e) separating the cellular components and non-whole cellular components of the bone marrow directly from the mixture of step (d) by density gradient centrifugation, wherein the separation by centrifugation establishes a cell density gradient;

(f) collecting non-cellular fractions, non-cellular components, or combinations thereof of predetermined density from the gradient;

(g) washing the non-cellular fractions, non-cellular components, or combinations thereof to create a mixture;

(h) suspending the mixture of step (g) to a predetermined concentration in a polyampholyte cryoprotectant to form a coated biological composition;

(i) freezing the coated biological composition at a predetermined controlled rate; and

(j) packaging a bone blend having particles of 100 to 300 μm of demineralized cortical bone, mineralized cortical bone, and mineralized cancellous bone with the coated biological composition.

2. The method of claim 1 , wherein the coated biological composition is frozen in step (i) before packaging separately with the bone blend in step (i), and wherein the method further comprises:

(k) thawing the frozen coated biological composition;

(l) diluting the thawed coated biological composition in saline;

(m) mixing the coated biological composition with the bone blend; and

(n) implanting the diluted coated biological composition and the bone blend by packing, injection, or any other suitable means into a patient.

3. The method of claim 2 , wherein the step of thawing the frozen coated biological composition occurs at a temperature of 37 degrees C. for 2 to 3 minutes.

4. The method of claim 2 , wherein the thawed coated biological composition mixed with the bone blend is re-frozen after step (m) for storage prior to step (n).

5. The method of claim 2 , wherein the thawed coated biological composition mixed with the bone blend is refrigerated after step (m) for storage prior to step (n).

6. The method of claim 2 , wherein the thawed coated composition mixed with the bone blend is stored at room temperature after step (m) for storage prior to step (n).

7. The method of claim 1 , wherein the bone blend is intermixed with the coated biological composition prior to freezing in step (i).

8. The method of claim 7 , further comprising:

(k) thawing the frozen coated biological composition intermixed with the bone blend;

(l) diluting the thawed coated biological composition intermixed with the bone blend in saline; and

(m) implanting the diluted coated biological composition intermixed with the bone blend by packing, injection, or any other suitable means into a patient.

9. The method of claim 8 , wherein the step of thawing the frozen coated biological composition intermixed with the bone blend occurs at a temperature of 37 degrees C. for 2 to 3 minutes.

10. The method of claim 8 , wherein the thawed coated biological composition intermixed with the bone blend is re-frozen after step (l) for storage prior to step (m).

11. The method of claim 8 , wherein the thawed coated biological composition intermixed with the bone blend is refrigerated after step (l) for storage prior to step (m).

12. The method of claim 8 , wherein the thawed coated composition intermixed with the bone blend is stored at room temperature after step (l) for storage prior to step (m).

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 15, 2025
From: GANEY, TIMOTHY; WESTON, WENDY W.; QUEVEDO, MIGUEL; OGLESBY, STUART; ANDERSON, TRACY SCOTT
To: VIVEX BIOMEDICAL, INC.
Reel/Frame 071713/0017 →
CHANGE OF NAME Recorded Jul 15, 2025
From: VIVEX BIOMEDICAL, INC.
To: VIVEX BIOLOGICS, INC.
Reel/Frame 071945/0482 →
CHANGE OF NAME Recorded Jul 15, 2025
From: VIVEX BIOLOGICS, INC.
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 071945/0516 →
Continuity (2)
Division 15818147 · Nov 20, 2017
Related Publication 20220288274A1 · Sep 15, 2022
References Cited (19)
US 5837539A · Caplan · 1998 [cited by examiner]
US 20020132012A1 · Scarborough · 2002 [cited by examiner]
US 20040097612A1 · Rosenberg et al. · 2004 [cited by applicant]
US 20050013872A1 · Freyman · 2005 [cited by examiner]
US 20100112032A1 · Guelcher et al. · 2010 [cited by applicant]
US 20120053692A1 · Voor · 2012 [cited by examiner]
US 20140065240A1 · Mitsialis et al. · 2014 [cited by applicant]
WO 2014159662 · 2014 [cited by applicant]
Brockbank et al., Chapter 8: Tissue Preservation, Advances in Biopreservation, Jun. 2006 (Year: 2006). [cited by examiner]
Schenke-Layland et al., Ann. Thorac Surg, 2006 (Year: 2006). [cited by examiner]
Thibault et al Adv Healthc Mater., 2013 (Year: 2013). [cited by examiner]
Thesaurus.com/can be, retrieved from the internet (Jun. 24, 2021): https://www.thesaurus.com/browse/can%20be (Year: 2021). [cited by applicant]
Al-Nedawi et al., Cell Cycle (2009), vol. 8, Issue 13, pp. 2014-2018 (Year: 2009). [cited by applicant]
Camussi et al., Kidney International (2010), vol. 78, pp. 838-848 (Year: 2010). [cited by applicant]
Mathivanan et al.Journal of Proteomics, vol. 73 (2010), pp. 1907-1920 (Year: 2010). [cited by applicant]
Matsumura et al., Cell Transplantation, vol. 19, pp. 691-699, 2010 (Year: 2010). [cited by applicant]
Matsumura et al., Journal of Biomaterials Science, Polymer Edition, 2013 (Year: 2013). [cited by applicant]
Weston et al., BioDrugs (2019) 33: 137-158. [cited by applicant]
Williams et al., Circulation Research, 2011; 109: 907-922. [cited by applicant]